2015
DOI: 10.1590/0004-282x20150001
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the efficacy of sodium valproate in convulsive status epilepticus following to ıschemic stroke

Abstract: Objective : Convulsive status epilepticus (CSE) is very rarely observed after ischaemic stroke. Sodium valproate (SV) is one of the agents used in the treatment of CSE, but its role still controversial, and its degree of efficacy in treating CSE that develops following stroke is unclear. Method : We evaluated 19 patients who were treated with intravenous (IV) SV (20 mg/kg, 2 mg/kg/h-12h) after diazepam. Patients’ modified Rankin scores (mRS), SE types, and changes in biochemical parameters after treatment were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
(16 reference statements)
0
2
0
Order By: Relevance
“…Nevertheless, limited studies reported the negative effects of sodium valproate on cardiac function. For example, Özdemir et al [16] examined the side effects of sodium valproate [20 mg/kg and 2 mg/kg/h-12h] in 19 adult patients with status epilepticus following ischemic stroke. They demonstrated that sodium valproate led to systemic side effects such as hypotension, abnormal heart rate, and respiratory failure in these patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, limited studies reported the negative effects of sodium valproate on cardiac function. For example, Özdemir et al [16] examined the side effects of sodium valproate [20 mg/kg and 2 mg/kg/h-12h] in 19 adult patients with status epilepticus following ischemic stroke. They demonstrated that sodium valproate led to systemic side effects such as hypotension, abnormal heart rate, and respiratory failure in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…Sodium valproate interacts with drugs such as phenobarbital, phenytoin, carbamazepine, lamotrigine, rifampin, ethosuximide, and primidone [15]. Recent studies have supposed that sodium valproate may result in cardiac failure in children [16]; however, its effect on cardiac function is still controversial. Therefore, researching the effect of sodium valproate on heart function and structure in children is valuable for the prevention of heart problems in these cases.…”
Section: Introductionmentioning
confidence: 99%